Adamis Pharmaceuticals (ADMP) Ramps to Session Highs on Volume
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/19/2024
- Nasdaq, S&P tumble as Netflix, chip stocks drag; AmEx boosts Dow
- Sony/Apollo bid for Paramount could be worth as much as $29 billion - Source
- Netflix Q1 earnings top estimates on blowout subscriber growth
- Wall St indexes split, Treasuries dip amid earnings, geopolitical crosscurrents
- Gold prices rally past $2,400 on reports of Israel strikes on Iran
- Tritium DCFC Limited (DCFC): Three Australian subsidiaries were determined to be insolvent or likely to become insolvent
- Hasbro (HAS) Announces Resignation of Cynthia Williams, President of Wizards of the Coast and Hasbro Gaming
- Jabil falls after placing CEO on paid leave amid internal investigation
- Frontier Communications (FYBR) says third party had gained unauthorized access to portions of its information technology environment
- Ibotta (IBTA) Prices 6.56M Share IPO at $88/sh
- Midday movers: Netflix, Super Micro fall; Paramount Global gains
- After-hours movers: Netflix, Intuitive Surgical, Nordstrom, KB Home
- Midday movers: Tesla, Blackstone, Las Vegas Sands fall; DR Horton rises
- After-hours movers: Alcoa rises; Equifax and Las Vegas Sands fall
- Midday movers: Travelers, JB Hunt fall; United Airlines rises
Generic EpiPen Pricing Parity and Less than 1% Share Supports $10 Adamis (ADMP) Target Price - Maxim Group
August 29, 2016 1:04 PM EDTAfter surging 25% on Friday as investors focused on the company's PFS an alternative to EpiPen, Adamis Pharmaceuticals (NASDAQ: ADMP) is down 15% Monday as Mylan (NYSE: MYL) announced the launch of a generic version for a list price of $300 per two-pack carton, a 50% saving.
Commenting on Adamis amid the news, Maxim Group analyst Jason Kolbert said price parity with existing generics at time of launch and modest... More
Adamis Pharmaceuticals (ADMP) Gains Despite Mylan's Generic EpiPen
August 29, 2016 7:57 AM EDTAdamis Pharmaceuticals (NASDAQ: ADMP) is gaining again despite news that Mylan (NYSE: MYL)... More
Adamis Pharmaceuticals (ADMP) Open to New Partnerships for EpiPen Alternative; Targets New NDA Submission by Year End - Bloomberg
August 26, 2016 4:17 PM EDTAdamis Pharmaceuticals (NASDAQ: ADMP) Open to New Partnerships for EpiPen Alternative; Targets New NDA Submission by Year End - Bloomberg
... More
